loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r1_cep_2004_297___rev_05 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PIERRE FABRE MEDICAMENT Gaillac FR (1)

filter

01 Vinorelbine tartrate (1)

filter

01 France (1)

filter

01 Valid (1)

URL Supplier Web Content
R1-CEP 2004-297 - Rev 05
Valid
Chemical
2020-02-25
2107
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-297 - Rev 05 of Pierre Fabre Medicament Gaillac Fr

Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-297 - Rev 05 of Pierre Fabre Medicament Gaillac Fr 1

20

Pierre Fabre Medicament Gaillac Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for The 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group.

One of their significant offerings is Vinorelbine tartrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-297 - Rev 05

This Chemical Type CEP, issued on February 25, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2107 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY